메뉴 건너뛰기




Volumn 33, Issue 5, 2008, Pages 455-462

Therapeutic targets for urinary incontinence

Author keywords

[No Author keywords available]

Indexed keywords

6 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,4 BENZODIOXAN 2 CARBOXYLIC ACID; AV 608; BESIPIRDINE; CENTRAL NERVOUS SYSTEM AGENTS; CLENBUTEROL; DARIFENACIN; DULOXETINE; EP 0748807; FE 106483; FESOTERODINE; FR 2769914; GRC 6211; IMIDAFENACIN; JP 2002114684; JP 2004123649; JP 2005225845; JP 2005239578; JP 2006306746; JP 205289890; KUC 7483; MIRABEGRON; MN 246; NAFTOPIDIL; ONO 8539; ONO 8569; OXYBUTYNIN; PROPIVERINE; PSD 503; RO 3202904; RO 32029704; SOLABEGRON; SOLIFENACIN; SOU 003; SSR 240600; SVT 40776; TA 5538; TAMSULOSIN; TOLTERODINE; TROSPIUM CHLORIDE; UNINDEXED DRUG; URINARY TRACT AGENT; US 2005154020; US 2005154022; US 2007270436; US 6693136; VARDENAFIL; WO 1993003725; WO 1993017007; WO 1997017345; WO 1998004546; WO 1998043942; WO 1999006383; WO 1999025710; WO 199906382; WO 2000055143; WO 2000078716; WO 2001064671; WO 2002018348; WO 2002044159; WO 2002114684; WO 2003016254; WO 2003097060; WO 2003099765; WO 2003106444; WO 2004004714; WO 2004005257; WO 2004017960; WO 2004031118; WO 2005000356; WO 2005005395; WO 2005005397; WO 2005009469; WO 2005013989; WO 2005039569; WO 2005058790; WO 2005095359; WO 2005108389; WO 2006002051; WO 2006014024; WO 2006072458; WO 2006082872; WO 2006088075; WO 2006103511; WO 2006106421; WO 2006121104; WO 2006121106; WO 2007024593; WO 2007025899; WO 20070328454; WO 2007038209; WO 2007071358; WO 2007072089; WO 2007072090; WO 2007072091; WO 2007072094; WO 2007072095; WO 2007093542; WO 2007113276; WO 2007132841; WO 2008000645; WO 2008007661; WO 2008007664; WO 2008023720;

EID: 45849084694     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2008.033.05.1204517     Document Type: Review
Times cited : (5)

References (38)
  • 1
    • 45849091801 scopus 로고    scopus 로고
    • Prous Science Disease Briefings: Urinary Incontinence (online publication). Updated 2008.
    • Prous Science Disease Briefings: Urinary Incontinence (online publication). Updated 2008.
  • 2
    • 29844449648 scopus 로고    scopus 로고
    • Urinary incontinence in women
    • Norton, P., Brubaker, L. Urinary incontinence in women. Lancet 2006, 367(9504): 57-67.
    • (2006) Lancet , vol.367 , Issue.9504 , pp. 57-67
    • Norton, P.1    Brubaker, L.2
  • 4
    • 38449089664 scopus 로고    scopus 로고
    • Pharmacologic management of overactive bladder
    • Lam, S., Hilas, O. Pharmacologic management of overactive bladder. Clin Interv Aging 2007, 2(3): 337-45.
    • (2007) Clin Interv Aging , vol.2 , Issue.3 , pp. 337-345
    • Lam, S.1    Hilas, O.2
  • 5
    • 25444453782 scopus 로고    scopus 로고
    • Overactive bladder: Epidemiology and social impact
    • Tubaro, A., Palleschi, G. Overactive bladder: Epidemiology and social impact. Curr Opin Obstet Gynecol 2005, 17(5): 507-11.
    • (2005) Curr Opin Obstet Gynecol , vol.17 , Issue.5 , pp. 507-511
    • Tubaro, A.1    Palleschi, G.2
  • 6
    • 0035184357 scopus 로고    scopus 로고
    • Pharmacological agents for the treatment of urinary incontinence due to overactive bladder
    • Wein, A.J. Pharmacological agents for the treatment of urinary incontinence due to overactive bladder. Expert Opin Investig Drugs 2001, 10(1): 65-83.
    • (2001) Expert Opin Investig Drugs , vol.10 , Issue.1 , pp. 65-83
    • Wein, A.J.1
  • 7
    • 0032942662 scopus 로고    scopus 로고
    • Advances in the pharmacological control of the bladder
    • Andersson, K.E. Advances in the pharmacological control of the bladder. Exp Physiol 1999, 84(1): 195-213.
    • (1999) Exp Physiol , vol.84 , Issue.1 , pp. 195-213
    • Andersson, K.E.1
  • 8
    • 37849008726 scopus 로고    scopus 로고
    • α-Blockers improve chronic ischaemia of the lower urinary tract in patients with lower urinary tract symptoms
    • Pinggera, G.M., Mitterberger, M., Pallwein, L. et al. α-Blockers improve chronic ischaemia of the lower urinary tract in patients with lower urinary tract symptoms. BJU Int 2008, 101(3): 319-24.
    • (2008) BJU Int , vol.101 , Issue.3 , pp. 319-324
    • Pinggera, G.M.1    Mitterberger, M.2    Pallwein, L.3
  • 9
    • 37649019743 scopus 로고    scopus 로고
    • In vivo study on the effects of alpha(1)-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs
    • Noguchi, Y., Ohtake, A., Suzuki, M., Sasamata, M. In vivo study on the effects of alpha(1)-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs. Eur J Pharmacol 2008, 580(1-2): 256-61.
    • (2008) Eur J Pharmacol , vol.580 , Issue.1-2 , pp. 256-261
    • Noguchi, Y.1    Ohtake, A.2    Suzuki, M.3    Sasamata, M.4
  • 10
    • 0037008377 scopus 로고    scopus 로고
    • Effects of intrathecal injection of tamsulosin and naftopidil, alpha-1A and -1D adrenergic receptor antagonists, on bladder activity in rats
    • Sugaya, K., Nishijima, S., Miyazato, M., Ashitomi, K., Hatano, T., Ogawa, Y. Effects of intrathecal injection of tamsulosin and naftopidil, alpha-1A and -1D adrenergic receptor antagonists, on bladder activity in rats. Neurosci Lett 2002, 328(1): 74-6.
    • (2002) Neurosci Lett , vol.328 , Issue.1 , pp. 74-76
    • Sugaya, K.1    Nishijima, S.2    Miyazato, M.3    Ashitomi, K.4    Hatano, T.5    Ogawa, Y.6
  • 11
    • 20444499446 scopus 로고    scopus 로고
    • Function of the lower urinary tract in mice lacking alpha1d-adrenoceptor
    • Chen, Q., Takahashi, S., Zhong, S. et al. Function of the lower urinary tract in mice lacking alpha1d-adrenoceptor. J Urol 2005, 174(1): 370-4.
    • (2005) J Urol , vol.174 , Issue.1 , pp. 370-374
    • Chen, Q.1    Takahashi, S.2    Zhong, S.3
  • 12
    • 0034796234 scopus 로고    scopus 로고
    • Inhibition of the contractile responses of isolated human and rat bladders by clenbuterol
    • Hudman, D., Elliott, R.A., Whitaker, P., Terry, T.R., Sandhu, D.P., Norman, R.I. Inhibition of the contractile responses of isolated human and rat bladders by clenbuterol. J Urol 2001, 166(5): 1969-73.
    • (2001) J Urol , vol.166 , Issue.5 , pp. 1969-1973
    • Hudman, D.1    Elliott, R.A.2    Whitaker, P.3    Terry, T.R.4    Sandhu, D.P.5    Norman, R.I.6
  • 13
    • 34147121696 scopus 로고    scopus 로고
    • Relaxation of human detrusor muscle by selective beta-2 and beta-3 agonists and endogenous catecholamines
    • Badawi, J.K., Seja, T., Uecelehan, H., Honeck, P., Kwon, S.T., Bross, S., Langbein, S. Relaxation of human detrusor muscle by selective beta-2 and beta-3 agonists and endogenous catecholamines. Urology 2007, 69(4): 785-90.
    • (2007) Urology , vol.69 , Issue.4 , pp. 785-790
    • Badawi, J.K.1    Seja, T.2    Uecelehan, H.3    Honeck, P.4    Kwon, S.T.5    Bross, S.6    Langbein, S.7
  • 14
    • 34548840602 scopus 로고    scopus 로고
    • GW427353 (solabegron), a novel, selective beta3-adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dog
    • Hicks, A., McCafferty, G.P., Riedel, E. et al. GW427353 (solabegron), a novel, selective beta3-adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dog. J Pharmacol Exp Ther 2007, 323(1): 202-9.
    • (2007) J Pharmacol Exp Ther , vol.323 , Issue.1 , pp. 202-209
    • Hicks, A.1    McCafferty, G.P.2    Riedel, E.3
  • 15
    • 34247205378 scopus 로고    scopus 로고
    • Effect of (R)-[2-(2- aminothiazol-4-yl)-4′-2-[(2-hydroxy-2-phenylethyl)amino]ethyl] acetanilide (YM178), a novel selective beta3-adrenoceptor ago nist, on bladder function
    • Takasu, T., Ukai, M., Sato, S. et al. Effect of (R)-[2-(2- aminothiazol-4-yl)-4′-2-[(2-hydroxy-2-phenylethyl)amino]ethyl] acetanilide (YM178), a novel selective beta3-adrenoceptor ago nist, on bladder function. J Pharmacol Exp Ther 2007, 321(2): 642-7.
    • (2007) J Pharmacol Exp Ther , vol.321 , Issue.2 , pp. 642-647
    • Takasu, T.1    Ukai, M.2    Sato, S.3
  • 16
    • 40549112321 scopus 로고    scopus 로고
    • Assessment of muscarinic receptor subtypes in human and rat lower urinary tract by tissue segment binding assay
    • Anisuzzaman, A.S., Morishima, S., Suzuki, F. et al. Assessment of muscarinic receptor subtypes in human and rat lower urinary tract by tissue segment binding assay. J Pharmacol Sci 2008, 106(2): 271-9.
    • (2008) J Pharmacol Sci , vol.106 , Issue.2 , pp. 271-279
    • Anisuzzaman, A.S.1    Morishima, S.2    Suzuki, F.3
  • 17
    • 34447127491 scopus 로고    scopus 로고
    • Analysis of pharmacological effects of drugs used for treatment of urinary disturbance based on anticholinergic and smooth muscle-relaxing effects
    • Takayanagi, R., Mizushima, H., Ozeki, T., Yokoyama, H., Iga, T., Yamada, Y. Analysis of pharmacological effects of drugs used for treatment of urinary disturbance based on anticholinergic and smooth muscle-relaxing effects. Biol Pharm Bull 2007, 30(7): 1297-300.
    • (2007) Biol Pharm Bull , vol.30 , Issue.7 , pp. 1297-1300
    • Takayanagi, R.1    Mizushima, H.2    Ozeki, T.3    Yokoyama, H.4    Iga, T.5    Yamada, Y.6
  • 18
    • 2342444247 scopus 로고    scopus 로고
    • Antimuscarinics for the treatment of overactive bladder: Current options and emerging therapies
    • Hegde, S.S., Mammen, M., Jasper, J.R. Antimuscarinics for the treatment of overactive bladder: Current options and emerging therapies. Curr Opin Investig Drugs 2004, 5(1): 40-9.
    • (2004) Curr Opin Investig Drugs , vol.5 , Issue.1 , pp. 40-49
    • Hegde, S.S.1    Mammen, M.2    Jasper, J.R.3
  • 19
    • 33744817600 scopus 로고    scopus 로고
    • Localization of M2 and M3 muscarinic receptors in human bladder disorders and their clinical correlations
    • Mukerji, G., Yiangou, Y., Grogono, J., Underwood, J., Agarwal, S.K., Khullar, V., Anand, P. Localization of M2 and M3 muscarinic receptors in human bladder disorders and their clinical correlations. J Urol 2006, 176(1): 367-73.
    • (2006) J Urol , vol.176 , Issue.1 , pp. 367-373
    • Mukerji, G.1    Yiangou, Y.2    Grogono, J.3    Underwood, J.4    Agarwal, S.K.5    Khullar, V.6    Anand, P.7
  • 20
    • 0042809980 scopus 로고    scopus 로고
    • Urethral closure mechanisms under sneeze-induced stress condition in rats: A new animal model for evaluation of stress urinary incontinence
    • Kamo, I., Torimoto, K., Chancellor, M.B., de Groat, W.C., Yoshimura, N. Urethral closure mechanisms under sneeze-induced stress condition in rats: A new animal model for evaluation of stress urinary incontinence. Am J Physiol Regul Integr Comp Physiol 2003, 285(2): R356-65.
    • (2003) Am J Physiol Regul Integr Comp Physiol , vol.285 , Issue.2
    • Kamo, I.1    Torimoto, K.2    Chancellor, M.B.3    de Groat, W.C.4    Yoshimura, N.5
  • 21
    • 23044514910 scopus 로고    scopus 로고
    • How the monoamine transporter garden grows
    • Ruoho, A.E. How the monoamine transporter garden grows. Mol Pharmacol 2005, 68(2): 272-4.
    • (2005) Mol Pharmacol , vol.68 , Issue.2 , pp. 272-274
    • Ruoho, A.E.1
  • 22
    • 34447322530 scopus 로고    scopus 로고
    • Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: Scientific basis for overlapping clinical efficacy from a single drug, duloxetine
    • Thor, K.B., Kirby, M., Viktrup, L. Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: Scientific basis for overlapping clinical efficacy from a single drug, duloxetine. Int J Clin Pract 2007, 61(8): 1247-8.
    • (2007) Int J Clin Pract , vol.61 , Issue.8 , pp. 1247-1248
    • Thor, K.B.1    Kirby, M.2    Viktrup, L.3
  • 23
    • 4444267411 scopus 로고    scopus 로고
    • Duloxetine: Mechanism of action at the lower urinary tract and Onuf's nucleus
    • Jost, W., Marsalek, P. Duloxetine: Mechanism of action at the lower urinary tract and Onuf's nucleus. Clin Auton Res 2004, 14(4): 220-7.
    • (2004) Clin Auton Res , vol.14 , Issue.4 , pp. 220-227
    • Jost, W.1    Marsalek, P.2
  • 24
    • 33847049918 scopus 로고    scopus 로고
    • Characterization and functional role of androgen-dependent PDE5 activity in the bladder
    • Filippi, S., Morelli, A., Sandner, P. et al. Characterization and functional role of androgen-dependent PDE5 activity in the bladder. Endocrinology 2007, 148(3): 1019-29.
    • (2007) Endocrinology , vol.148 , Issue.3 , pp. 1019-1029
    • Filippi, S.1    Morelli, A.2    Sandner, P.3
  • 25
    • 0036479319 scopus 로고    scopus 로고
    • Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells
    • Rybalkin, S.D., Rybalkina, I.G., Feil, R., Hofmann, F., Beavo, J.A. Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells. J Biol Chem 2002, 277(5): 3310-7.
    • (2002) J Biol Chem , vol.277 , Issue.5 , pp. 3310-3317
    • Rybalkin, S.D.1    Rybalkina, I.G.2    Feil, R.3    Hofmann, F.4    Beavo, J.A.5
  • 26
    • 13244258565 scopus 로고    scopus 로고
    • Phosphodiesterase 5 enzyme and its inhibitors: Update on pharmacological and therapeutical aspects
    • Kulkarni, S.K., Patil, C.S. Phosphodiesterase 5 enzyme and its inhibitors: Update on pharmacological and therapeutical aspects. Methods Find Exp Clin Pharmacol 2004, 26(10): 789-99.
    • (2004) Methods Find Exp Clin Pharmacol , vol.26 , Issue.10 , pp. 789-799
    • Kulkarni, S.K.1    Patil, C.S.2
  • 27
    • 4143147473 scopus 로고    scopus 로고
    • Detrusor responses to prostaglandin E2 and bladder outlet obstruction in wild-type and Ep1 receptor knockout mice
    • Schröder, A., Newgreen, D., Andersson, K.E. Detrusor responses to prostaglandin E2 and bladder outlet obstruction in wild-type and Ep1 receptor knockout mice. J Urol 2004, 172(3): 1166-70.
    • (2004) J Urol , vol.172 , Issue.3 , pp. 1166-1170
    • Schröder, A.1    Newgreen, D.2    Andersson, K.E.3
  • 28
    • 33646758221 scopus 로고    scopus 로고
    • Prostaglandin facilitates afferent nerve activity via EP1 receptors during urinary bladder inflammation in rats
    • Ikeda, M., Kawatani, M., Maruyama, T., Ishihama, H. Prostaglandin facilitates afferent nerve activity via EP1 receptors during urinary bladder inflammation in rats. Biomed Res 2006, 27(2): 49-54.
    • (2006) Biomed Res , vol.27 , Issue.2 , pp. 49-54
    • Ikeda, M.1    Kawatani, M.2    Maruyama, T.3    Ishihama, H.4
  • 29
    • 33947207912 scopus 로고    scopus 로고
    • Urodynamic effects of a novel EP1 receptor antagonist in normal rats and rats with bladder outlet obstruction
    • Lee, T., Hedlund, P., Newgreen, D., Andersson, K.E. Urodynamic effects of a novel EP1 receptor antagonist in normal rats and rats with bladder outlet obstruction. J Urol 2007, 177(4): 1562-7.
    • (2007) J Urol , vol.177 , Issue.4 , pp. 1562-1567
    • Lee, T.1    Hedlund, P.2    Newgreen, D.3    Andersson, K.E.4
  • 30
    • 0037008384 scopus 로고    scopus 로고
    • Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats
    • Katofiasc, M.A., Nissen, J., Audia, J.E., Thor, K.B. Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats. Life Sci 2002, 71(11): 1227-36.
    • (2002) Life Sci , vol.71 , Issue.11 , pp. 1227-1236
    • Katofiasc, M.A.1    Nissen, J.2    Audia, J.E.3    Thor, K.B.4
  • 31
    • 0037377087 scopus 로고    scopus 로고
    • Substance P via NK1 receptor facilitates hyperactive bladder afferent signaling via action of ROS
    • Chien, C.T., Yu, H.J., Lin, T.B., Lai, M.K., Hsu, S.M. Substance P via NK1 receptor facilitates hyperactive bladder afferent signaling via action of ROS. Am J Physiol Renal Physiol 2003, 284(4): F840-51.
    • (2003) Am J Physiol Renal Physiol , vol.284 , Issue.4
    • Chien, C.T.1    Yu, H.J.2    Lin, T.B.3    Lai, M.K.4    Hsu, S.M.5
  • 32
    • 2642587350 scopus 로고    scopus 로고
    • Potential therapeutic targets for neurokinin-1 receptor antagonists
    • Duffy, R.A. Potential therapeutic targets for neurokinin-1 receptor antagonists. Expert Opin Emerg Drugs 2004, 9(1): 9-21.
    • (2004) Expert Opin Emerg Drugs , vol.9 , Issue.1 , pp. 9-21
    • Duffy, R.A.1
  • 34
    • 44249114326 scopus 로고    scopus 로고
    • Inter-dependent regulation of afferent renal nerve activity and renal function: Role of TRPV1, NK1 and CGRP receptors
    • In press
    • Xie, C., Sachs, J.R., Wang, D.H. Inter-dependent regulation of afferent renal nerve activity and renal function: Role of TRPV1, NK1 and CGRP receptors. J Pharmacol Exp Ther 2008, In press.
    • (2008) J Pharmacol Exp Ther
    • Xie, C.1    Sachs, J.R.2    Wang, D.H.3
  • 35
    • 0036668564 scopus 로고    scopus 로고
    • Vasopressin V2 receptor antagonists
    • Verbalis, J.G. Vasopressin V2 receptor antagonists. J Mol Endocrinol 2002, 29(1): 1-9.
    • (2002) J Mol Endocrinol , vol.29 , Issue.1 , pp. 1-9
    • Verbalis, J.G.1
  • 36
    • 8644266778 scopus 로고    scopus 로고
    • Development of water transport in the collecting duct
    • Bonilla-Felix, M. Development of water transport in the collecting duct. Am J Physiol Renal Physiol 2004, 287(6): F1093-101.
    • (2004) Am J Physiol Renal Physiol , vol.287 , Issue.6
    • Bonilla-Felix, M.1
  • 37
    • 0033104723 scopus 로고    scopus 로고
    • Contribution of delayed rectifier potassium currents to the electrical activity of murine colonic smooth muscle
    • Koh, S.D., Ward, S.M., Dick, G.M. et al. Contribution of delayed rectifier potassium currents to the electrical activity of murine colonic smooth muscle. J Physiol 1999, 515(Pt. 2): 475-87.
    • (1999) J Physiol , vol.515 , Issue.PART. 2 , pp. 475-487
    • Koh, S.D.1    Ward, S.M.2    Dick, G.M.3
  • 38
    • 0037850066 scopus 로고    scopus 로고
    • Properties and molecular basis of the mouse urinary bladder voltage-gated K+ current
    • Thorneloe, K.S., Nelson, M.T. Properties and molecular basis of the mouse urinary bladder voltage-gated K+ current. J Physiol 2003, 549(Pt. 1): 65-74.
    • (2003) J Physiol , vol.549 , Issue.PART. 1 , pp. 65-74
    • Thorneloe, K.S.1    Nelson, M.T.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.